Your browser doesn't support javascript.
loading
A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.
Lovell, Scott; Zhang, Leran; Kryza, Thomas; Neodo, Anna; Bock, Nathalie; De Vita, Elena; Williams, Elizabeth D; Engelsberger, Elisabeth; Xu, Congyi; Bakker, Alexander T; Maneiro, Maria; Tanaka, Reiko J; Bevan, Charlotte L; Clements, Judith A; Tate, Edward W.
Afiliação
  • Lovell S; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • Zhang L; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • Kryza T; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Neodo A; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Institute of Health & Biomedical Innovation and School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Bock N; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • De Vita E; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Institute of Health & Biomedical Innovation and School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Williams ED; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • Engelsberger E; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Institute of Health & Biomedical Innovation and School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Xu C; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • Bakker AT; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • Maneiro M; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • Tanaka RJ; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
  • Bevan CL; Department of Bioengineering, Imperial College London, London SW7 2AZ, U.K.
  • Clements JA; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, U.K.
  • Tate EW; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Institute of Health & Biomedical Innovation and School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
J Am Chem Soc ; 143(23): 8911-8924, 2021 06 16.
Article em En | MEDLINE | ID: mdl-34085829
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Calicreínas / Antígeno Prostático Específico / Cumarínicos / Inibidores Enzimáticos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: J Am Chem Soc Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Calicreínas / Antígeno Prostático Específico / Cumarínicos / Inibidores Enzimáticos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: J Am Chem Soc Ano de publicação: 2021 Tipo de documento: Article